pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Drugs
by stage
  • Marketed
  • Phase 3
  • Phase 2
  • Phase 1
  • Preclinical
browse
  • Most catalysts
  • Recently active
  • All drugs →
  • Companies
  • Patent cliff
Calendar
what
  • Trial readouts
  • PDUFA dates
  • Approvals
  • Earnings
when
  • Upcoming
  • Month grid
  • Recently passed
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
  • Drugs
  • Calendar
  • Companies
Hubs
  • Topics
  • Patent cliff
  • Publications
  • Readouts
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
STAT·Jul 27·1 min read
save

Global HIV funding drops 18%, raising fears of epidemic resurgence

Jul 27, 2026·read at STAT ↗Negative

A new UNAIDS report warns that the world could see a rebound of HIV infections after donor financing fell sharply last year.

Government contributions dropped by more than $1.5 billion to $7.3 billion in 2025, an 18 percent decline and the lowest level in almost twenty years. The United States still accounts for about 74 percent of donor government money.

Prevention programmes, especially in sub‑Saharan Africa where donor support once covered 83 percent of costs, are now at risk. The report also cites high national debt and setbacks in human‑rights and gender‑equality policies as additional concerns.

source

This writeup was produced by pharmadog from original reporting by STAT.

Original headline: “STAT+: HIV resurgence is feared as global funding to combat the disease falls 18%”

read at STAT ↗
483 words · retrieved Jul 27
sharex / twitterlinkedin

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?

companies & drugs in this story

companies
AMGEN
topics
Infectious DiseasePeptide Therapeutic

related stories

  • 7h agoTango plans 14% workforce cut, mainly of research staffBioSpace
  • Jul 28STAT+: Pharmalittle: We’re reading about FDA views on a Duchenne drug, GSK cost savings, and moreSTAT
  • Jun 2910 clinical trials to watch in the second half of 2026BioPharma Dive
  • Dec 22Fierce Biotech Fundraising Tracker '26: Nouscom nabs $135M series D; Estuary channels $93M series AFierce Biotech
  • Oct 14Zealand inks $1.2B Generate pact to add multispecific proteins to obesity pipelineFierce Biotech